Latest Patents News

IperionX has secured A$70 million through a share placement to fast-track expansion of its titanium production capacity in the U.S., aligning closely with Department of Defense priorities.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.

Argenica Therapeutics has dosed the final patient in its Phase 2 trial for ARG-007 in acute ischaemic stroke, with topline results expected in Q3 2025. Meanwhile, the FDA has placed a clinical hold on its US trial application, introducing uncertainty for US development.

Reach Resources has significantly increased its gold resource inventory at the Murchison South project, with combined estimates for Blue Heaven and Pansy Pit now totaling approximately 67,100 ounces. Strong metallurgical results and exploration upside highlight the project's potential.

Sunrise Energy Metals reports strong high-grade scandium drill results at Syerston and secures $7.5 million to accelerate project development. The company is updating its feasibility study amid growing market demand and geopolitical supply pressures.

Papyrus Australia has fully impaired its investments in its Egyptian joint ventures PPYEg and EBFC, citing lack of returns and governance issues ahead of its 2025 audited results.

Atomo Diagnostics has successfully placed $260,000 of the shortfall from its recent Share Purchase Plan, issuing over 14 million shares and options to sophisticated investors. This capital injection strengthens the company’s working capital position as it advances its rapid diagnostic test business.

Nanoveu Limited has completed a $2 million capital raise through a strategic placement and exercised options, reinforcing its position in advanced semiconductor and 3D visualization technologies.

Firebird Metals has secured two key patents for its proprietary Lithium Manganese Iron Phosphate (LMFP) battery materials, reinforcing its position in the emerging $20 billion LMFP market. The company’s integrated production approach and expanding IP portfolio set the stage for global growth amid shifting technology controls.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

Lithium Universe has completed the acquisition of New Age Minerals, gaining exclusive rights to a patented solar panel recycling technology that promises to revolutionize critical metal recovery. This move complements its lithium refinery ambitions and positions the company at the forefront of sustainable clean energy solutions.

Capral Limited has agreed to acquire Perth-based aluminium systems distributor Comsupply Ltd, aiming to strengthen its foothold in Western Australia’s building systems market.